{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:32:12Z","timestamp":1795026732186,"version":"4.10.2"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aging and cancer exhibit apparent links that we will examine in this review. The null hypothesis that aging and cancer coincide because both are driven by time, irrespective of the precise causes, can be confronted with the idea that aging and cancer share common mechanistic grounds that are referred to as \u2018hallmarks\u2019. Indeed, several hallmarks of aging also contribute to carcinogenesis and tumor progression, but some of the molecular and cellular characteristics of aging may also reduce the probability of developing lethal cancer, perhaps explaining why very old age (&gt;\u200990 years) is accompanied by a reduced incidence of neoplastic diseases. We will also discuss the possibility that the aging process itself causes cancer, meaning that the time-dependent degradation of cellular and supracellular functions that accompanies aging produces cancer as a byproduct or \u2018age-associated disease\u2019. Conversely, cancer and its treatment may erode health and drive the aging process, as this has dramatically been documented for cancer survivors diagnosed during childhood, adolescence, and young adulthood. We conclude that aging and cancer are connected by common superior causes including endogenous and lifestyle factors, as well as by a bidirectional crosstalk, that together render old age not only a risk factor of cancer but also an important parameter that must be considered for therapeutic decisions.<\/jats:p>","DOI":"10.1186\/s12943-024-02020-z","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:01:30Z","timestamp":1715983290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":206,"title":["Aging and cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"L\u00e9a","family":"Mont\u00e9gut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"L\u00f3pez-Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"issue":"1","key":"2020_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2020_CR2","unstructured":"Global age-sex. -specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of Disease Study 2021. Lancet. 2024."},{"issue":"2","key":"2020_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378.","journal-title":"Cell"},{"issue":"2","key":"2020_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cmet.2023.12.007","volume":"36","author":"L Guarente","year":"2024","unstructured":"Guarente L, Sinclair DA, Kroemer G. Human trials exploring anti-aging medicines. Cell Metab. 2024;36(2):354\u201376.","journal-title":"Cell Metab"},{"key":"2020_CR5","first-page":"68","volume":"5","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Joyce BT, Colicino E, Liu L, Zhang W, Dai Q, et al. Blood epigenetic age may predict cancer and mortality. EBioMedicine. 2016;5:68\u201373.","journal-title":"Blood Epigenetic Age may Predict Cancer Incidence Mortal EBioMedicine"},{"issue":"3","key":"2020_CR6","doi-asserted-by":"publisher","first-page":"108891","DOI":"10.1016\/j.isci.2024.108891","volume":"27","author":"Q Jia","year":"2024","unstructured":"Jia Q, Chen C, Xu A, Wang S, He X, Shen G, et al. A biological age model based on physical examination data to predict mortality in a Chinese population. iScience. 2024;27(3):108891.","journal-title":"iScience"},{"issue":"7","key":"2020_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1200\/JCO.19.02407","volume":"38","author":"CE Matthews","year":"2020","unstructured":"Matthews CE, Moore SC, Arem H, Cook MB, Trabert B, H\u00e5kansson N, et al. Amount and intensity of leisure-time physical activity and lower cancer risk. J Clin Oncol. 2020;38(7):686\u201397.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2020_CR8","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.oneear.2023.11.002","volume":"6","author":"N Karavasiloglou","year":"2023","unstructured":"Karavasiloglou N, Thompson AS, Pestoni G, Knuppel A, Papier K, Cassidy A, et al. Adherence to the EAT-lancet reference diet is associated with a reduced risk of incident cancer and all-cause mortality in UK adults. One Earth. 2023;6(12):1726\u201334.","journal-title":"One Earth"},{"issue":"4","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1470-2045(18)30909-4","volume":"20","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019;20(4):483\u201393.","journal-title":"Lancet Oncol"},{"key":"2020_CR10","doi-asserted-by":"publisher","first-page":"101662","DOI":"10.1016\/j.canep.2019.101662","volume":"71","author":"WT Johnston","year":"2021","unstructured":"Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Sch\u00fcz J, Roman E. Childhood cancer: estimating regional and global incidence. Cancer Epidemiol. 2021;71:101662. Pt B).","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"2020_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1242\/dmm.024711","volume":"9","author":"D Carrero","year":"2016","unstructured":"Carrero D, Soria-Valles C, L\u00f3pez-Ot\u00edn C. Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells. Dis Model Mech. 2016;9(7):719\u201335.","journal-title":"Dis Model Mech"},{"key":"2020_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.arr.2017.11.003","volume":"41","author":"M Lebel","year":"2018","unstructured":"Lebel M, Monnat RJ. Jr. Werner syndrome (WRN) gene variants and their association with altered function and age-associated diseases. Ageing Res Rev. 2018;41:82\u201397.","journal-title":"Ageing Res Rev"},{"issue":"4s","key":"2020_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jid.2020.11.012","volume":"141","author":"ERH Rizza","year":"2021","unstructured":"Rizza ERH, DiGiovanna JJ, Khan SG, Tamura D, Jeskey JD, Kraemer KH. Xeroderma pigmentosum: a model for human premature aging. J Invest Dermatol. 2021;141(4s):976\u201384.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2020_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ymgme.2021.03.003","volume":"133","author":"M Ababou","year":"2021","unstructured":"Ababou M. Bloom syndrome and the underlying causes of genetic instability. Mol Genet Metab. 2021;133(1):35\u201348.","journal-title":"Mol Genet Metab"},{"key":"2020_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1073\/pnas.2024502118","volume":"118","author":"A Lombardi","year":"2021","unstructured":"Lombardi A, Arseni L, Carriero R, Compe E, Botta E, Ferri D, et al. Reduced levels of prostaglandin I(2) synthase: a distinctive feature of the cancer-free trichothiodystrophy. Proc Natl Acad Sci U S A. 2021;118:26.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"2020_CR16","doi-asserted-by":"publisher","first-page":"10151","DOI":"10.1073\/pnas.1610020113","volume":"113","author":"KS Reid-Bayliss","year":"2016","unstructured":"Reid-Bayliss KS, Arron ST, Loeb LA, Bezrookove V, Cleaver JE. Why cockayne syndrome patients do not get cancer despite their DNA repair deficiency. Proc Natl Acad Sci U S A. 2016;113(36):10151\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2020_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2013.12.028","volume":"156","author":"LB Gordon","year":"2014","unstructured":"Gordon LB, Rothman FG, L\u00f3pez-Ot\u00edn C, Misteli T. Progeria: a paradigm for translational medicine. Cell. 2014;156(3):400\u20137.","journal-title":"Cell"},{"key":"2020_CR18","doi-asserted-by":"crossref","unstructured":"Batista NJ, Desai SG, Perez AM, Finkelstein A, Radigan R, Singh M et al. The molecular and cellular basis of Hutchinson-Gilford progeria syndrome and potential treatments. Genes (Basel). 2023;14(3).","DOI":"10.3390\/genes14030602"},{"issue":"11","key":"2020_CR19","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/ajmg.a.34249","volume":"155a","author":"R Cabanillas","year":"2011","unstructured":"Cabanillas R, Cadi\u00f1anos J, Villameytide JA, P\u00e9rez M, Longo J, Richard JM, et al. N\u00e9stor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am J Med Genet A. 2011;155a(11):2617\u201325.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2020_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41591-022-02193-4","volume":"29","author":"G Kroemer","year":"2023","unstructured":"Kroemer G, McQuade JL, Merad M, Andr\u00e9 F, Zitvogel L. Bodywide ecological interventions on cancer. Nat Med. 2023;29(1):59\u201374.","journal-title":"Nat Med"},{"issue":"3","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/S2542-5196(23)00021-9","volume":"7","author":"N Kliemann","year":"2023","unstructured":"Kliemann N, Rauber F, Bertazzi Levy R, Viallon V, Vamos EP, Cordova R, et al. Food processing and cancer risk in Europe: results from the prospective EPIC cohort study. Lancet Planet Health. 2023;7(3):e219\u201332.","journal-title":"Lancet Planet Health"},{"issue":"10","key":"2020_CR22","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1158\/2159-8290.CD-22-0504","volume":"12","author":"L Mont\u00e9gut","year":"2022","unstructured":"Mont\u00e9gut L, de Cabo R, Zitvogel L, Kroemer G. Science-Driven nutritional interventions for the prevention and treatment of cancer. Cancer Discov. 2022;12(10):2258\u201379.","journal-title":"Cancer Discov"},{"key":"2020_CR23","doi-asserted-by":"crossref","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024.","DOI":"10.1038\/s41571-024-00876-0"},{"issue":"1","key":"2020_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jshs.2022.10.003","volume":"12","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Fern\u00e1ndez-Garc\u00eda B, Lehmann HI, Li G, Kroemer G, L\u00f3pez-Ot\u00edn C, et al. Exercise sustains the hallmarks of health. J Sport Health Sci. 2023;12(1):8\u201335.","journal-title":"J Sport Health Sci"},{"issue":"Suppl 1","key":"2020_CR25","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/S0140-6736(23)02147-5","volume":"402","author":"AH Shreves","year":"2023","unstructured":"Shreves AH, Small SR, Travis RC, Matthews CE, Doherty A. Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis. Lancet. 2023;402(Suppl 1):S83.","journal-title":"Lancet"},{"issue":"2","key":"2020_CR26","doi-asserted-by":"publisher","first-page":"e208055","DOI":"10.1212\/WNL.0000000000208055","volume":"102","author":"KM Anthony","year":"2024","unstructured":"Anthony KM, Collins JM, Love SM, Stewart JD, Buchheit SF, Gondalia R, et al. Radon exposure, clonal hematopoiesis, and stroke susceptibility in the women\u2019s Health Initiative. Neurology. 2024;102(2):e208055.","journal-title":"Neurology"},{"issue":"7955","key":"2020_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","volume":"616","author":"W Hill","year":"2023","unstructured":"Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159\u201367.","journal-title":"Nature"},{"key":"2020_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.15698\/cst2024.03.294","volume":"8","author":"C L\u00f3pez-Ot\u00edn","year":"2024","unstructured":"L\u00f3pez-Ot\u00edn C, Kroemer G. The missing hallmark of health: psychosocial adaptation. Cell Stress. 2024;8:21\u201350.","journal-title":"Cell Stress"},{"issue":"11","key":"2020_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41569-023-00881-3","volume":"20","author":"M Abdellatif","year":"2023","unstructured":"Abdellatif M, Rainer PP, Sedej S, Kroemer G. Hallmarks of cardiovascular ageing. Nat Rev Cardiol. 2023;20(11):754\u201377.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2020_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","volume":"3","author":"ES Lau","year":"2021","unstructured":"Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48\u201358.","journal-title":"JACC CardioOncol"},{"issue":"4","key":"2020_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","volume":"26","author":"N Mars","year":"2020","unstructured":"Mars N, Koskela JT, Ripatti P, Kiiskinen TTJ, Havulinna AS, Lindbohm JV, et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat Med. 2020;26(4):549\u201357.","journal-title":"Nat Med"},{"issue":"1","key":"2020_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"1","key":"2020_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","volume":"35","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab. 2023;35(1):12\u201335.","journal-title":"Cell Metab"},{"key":"2020_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-biochem-062917-012239","volume":"87","author":"LJ Niedernhofer","year":"2018","unstructured":"Niedernhofer LJ, Gurkar AU, Wang Y, Vijg J, Hoeijmakers JHJ, Robbins PD. Nuclear genomic instability and aging. Annu Rev Biochem. 2018;87:295\u2013322.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"2020_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2016.112","volume":"17","author":"AS Sperling","year":"2017","unstructured":"Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17(1):5\u201319.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2020_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"17","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S, Libby P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol. 2020;17(3):137\u201344.","journal-title":"Nat Rev Cardiol"},{"issue":"7958","key":"2020_CR37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-023-05857-4","volume":"616","author":"WJ Wong","year":"2023","unstructured":"Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, et al. Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023;616(7958):747\u201354.","journal-title":"Nature"},{"issue":"7","key":"2020_CR38","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1200\/JCO.22.00857","volume":"41","author":"R Tian","year":"2023","unstructured":"Tian R, Wiley B, Liu J, Zong X, Truong B, Zhao S, et al. Clonal hematopoiesis and risk of incident lung cancer. J Clin Oncol. 2023;41(7):1423\u201333.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41568-021-00335-3","volume":"21","author":"N Kakiuchi","year":"2021","unstructured":"Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tissues. Nat Rev Cancer. 2021;21(4):239\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"7739","key":"2020_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565(7739):312\u20137.","journal-title":"Nature"},{"issue":"4","key":"2020_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3322\/caac.21765","volume":"73","author":"V Davalos","year":"2023","unstructured":"Davalos V, Esteller M. Cancer epigenetics in clinical practice. CA Cancer J Clin. 2023;73(4):376\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"6632","key":"2020_CR42","doi-asserted-by":"publisher","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","volume":"379","author":"AP Feinberg","year":"2023","unstructured":"Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379(6632):eaaw3835.","journal-title":"Science"},{"issue":"6658","key":"2020_CR43","doi-asserted-by":"publisher","first-page":"eabq5693","DOI":"10.1126\/science.abq5693","volume":"381","author":"A Haghani","year":"2023","unstructured":"Haghani A, Li CZ, Robeck TR, Zhang J, Lu AT, Ablaeva J, et al. DNA methylation networks underlying mammalian traits. Science. 2023;381(6658):eabq5693.","journal-title":"Science"},{"key":"2020_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonaf\u00e8 M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244\u201354.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"2020_CR45","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andr\u00e9 F, Auwerx J, Balmain A, et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell. 2024;187(7):1589\u2013616.","journal-title":"Cell"},{"issue":"6","key":"2020_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41571-018-0006-2","volume":"15","author":"B Routy","year":"2018","unstructured":"Routy B, Gopalakrishnan V, Daillere R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 2018;15(6):382\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"2020_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41571-023-00785-8","volume":"20","author":"AM Thomas","year":"2023","unstructured":"Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, et al. Gut OncoMicrobiome signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. Nat Rev Clin Oncol. 2023;20(9):583\u2013603.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2020_CR48","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-019-0504-5","volume":"25","author":"C Barcena","year":"2019","unstructured":"Barcena C, Valdes-Mas R, Mayoral P, Garabaya C, Durand S, Rodriguez F, et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat Med. 2019;25(8):1234\u201342.","journal-title":"Nat Med"},{"issue":"6371","key":"2020_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"8","key":"2020_CR50","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy B, Lenehan JG, Miller WH Jr., Jamal R, Messaoudene M, Daisley BA, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29(8):2121\u201332.","journal-title":"Nat Med"},{"key":"2020_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.12659\/MSM.889877","volume":"20","author":"SC Joseph","year":"2014","unstructured":"Joseph SC, Delcastilo E, Loukas M, Osiro S. Common cancers in centenarians. Med Sci Monit. 2014;20:18\u201323.","journal-title":"Med Sci Monit"},{"issue":"7","key":"2020_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41580-020-0234-z","volume":"21","author":"CM Roake","year":"2020","unstructured":"Roake CM, Artandi SE. Regulation of human telomerase in homeostasis and disease. Nat Rev Mol Cell Biol. 2020;21(7):384\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2020_CR53","doi-asserted-by":"publisher","first-page":"1286683","DOI":"10.3389\/fcell.2023.1286683","volume":"11","author":"ML Tornesello","year":"2023","unstructured":"Tornesello ML, Cerasuolo A, Starita N, Amiranda S, Bonelli P, Tuccillo FM, et al. Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations. Front Cell Dev Biol. 2023;11:1286683.","journal-title":"Front Cell Dev Biol"},{"issue":"6620","key":"2020_CR54","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.abq0607","volume":"378","author":"P Chun-On","year":"2022","unstructured":"Chun-On P, Hinchie AM, Beale HC, Gil Silva AA, Rush E, Sander C, et al. TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma. Science. 2022;378(6620):664\u20138.","journal-title":"Science"},{"issue":"9","key":"2020_CR55","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41568-022-00490-1","volume":"22","author":"J Gao","year":"2022","unstructured":"Gao J, Pickett HA. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies. Nat Rev Cancer. 2022;22(9):515\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2020_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/109454503322733144","volume":"6","author":"RL Brown","year":"2003","unstructured":"Brown RL. Stem cell exhaustion and atherosclerosis. J Anti Aging Med. 2003;6(3):279. discussion 80.","journal-title":"J Anti Aging Med"},{"issue":"2","key":"2020_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378.","journal-title":"Cell"},{"issue":"1","key":"2020_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2020_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.tips.2014.03.002","volume":"35","author":"M Ruat","year":"2014","unstructured":"Ruat M, Hoch L, Faure H, Rognan D. Targeting of smoothened for therapeutic gain. Trends Pharmacol Sci. 2014;35(5):237\u201346.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2020_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11357-011-9221-9","volume":"34","author":"MN Uddin","year":"2012","unstructured":"Uddin MN, Nishio N, Ito S, Suzuki H, Isobe K. Autophagic activity in thymus and liver during aging. Age (Dordr). 2012;34(1):75\u201385.","journal-title":"Age (Dordr)"},{"issue":"8","key":"2020_CR61","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, et al. Autophagy in healthy aging and disease. Nat Aging. 2021;1(8):634\u201350.","journal-title":"Nat Aging"},{"key":"2020_CR62","doi-asserted-by":"crossref","unstructured":"Chen X, Tsvetkov AS, Shen H-M, Isidoro C, Ktistakis NT, Linkermann A et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. 2024:1\u201334.","DOI":"10.1080\/15548627.2024.2319901"},{"key":"2020_CR63","first-page":"eaau0135","volume-title":"T cell stemness and dysfunction in tumors are triggered by a common mechanism","author":"SK Vodnala","year":"2019","unstructured":"Vodnala SK, Eil R, Kishton RJ, Sukumar M, Yamamoto TN, Ha N-H, et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Volume 363. New York, NY: Science; 2019. p. eaau0135. 6434."},{"issue":"2","key":"2020_CR64","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","volume":"13","author":"H-A Chen","year":"2023","unstructured":"Chen H-A, Ho Y-J, Mezzadra R, Adrover JM, Smolkin R, Zhu C, et al. Senescence rewires microenvironment sensing to facilitate antitumor immunity. Cancer Discov. 2023;13(2):432\u201353.","journal-title":"Cancer Discov"},{"issue":"2","key":"2020_CR65","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","volume":"13","author":"I Marin","year":"2023","unstructured":"Marin I, Boix O, Garcia-Garijo A, Sirois I, Caballe A, Zarzuela E, et al. Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discov. 2023;13(2):410\u201331.","journal-title":"Cancer Discov"},{"issue":"4","key":"2020_CR66","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ccell.2024.02.004","volume":"42","author":"M Colucci","year":"2024","unstructured":"Colucci M, Zumerle S, Bressan S, Gianfanti F, Troiani M, Valdata A, et al. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell. 2024;42(4):646\u2013e619.","journal-title":"Cancer Cell"},{"key":"2020_CR67","first-page":"1416","volume-title":"NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination","author":"M Ruscetti","year":"2018","unstructured":"Ruscetti M, Leibold J, Bott MJ, Fennell M, Kulick A, Salgado NR, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Volume 362. New York, NY: Science; 2018. pp. 1416\u201322. 6421."},{"issue":"18","key":"2020_CR68","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1016\/j.molcel.2021.08.028","volume":"81","author":"S Igelmann","year":"2021","unstructured":"Igelmann S, Lessard F, Uchenunu O, Bouchard J, Fernandez-Ruiz A, Rowell MC, et al. A hydride transfer complex reprograms NAD metabolism and bypasses senescence. Mol Cell. 2021;81(18):3848\u2013e6519.","journal-title":"Mol Cell"},{"issue":"6","key":"2020_CR69","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/0008-5472.CAN-18-3437","volume":"79","author":"T Saleh","year":"2019","unstructured":"Saleh T, Tyutyunyk-Massey L, Gewirtz DA. Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy. Cancer Res. 2019;79(6):1044\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"2020_CR70","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s43018-023-00712-x","volume":"5","author":"S Chaib","year":"2024","unstructured":"Chaib S, Lopez-Dominguez JA, Lalinde-Gutierrez M, Prats N, Marin I, Boix O, et al. The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nat Cancer. 2024;5(3):448\u201362.","journal-title":"Nat Cancer"},{"issue":"12","key":"2020_CR71","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s43018-022-00466-y","volume":"3","author":"A Shahbandi","year":"2022","unstructured":"Shahbandi A, Chiu FY, Ungerleider NA, Kvadas R, Mheidly Z, Sun MJS, et al. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. Nat Cancer. 2022;3(12):1513\u201333.","journal-title":"Nat Cancer"},{"issue":"8","key":"2020_CR72","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","volume":"19","author":"DV Faget","year":"2019","unstructured":"Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19(8):439\u201353.","journal-title":"Nat Rev Cancer"},{"key":"2020_CR73","doi-asserted-by":"crossref","unstructured":"Wang B, Han J, Elisseeff JH, Demaria M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 2024.","DOI":"10.1038\/s41580-024-00727-x"},{"issue":"72","key":"2020_CR74","doi-asserted-by":"publisher","first-page":"eabl7209","DOI":"10.1126\/sciimmunol.abl7209","volume":"7","author":"R Yamagishi","year":"2022","unstructured":"Yamagishi R, Kamachi F, Nakamura M, Yamazaki S, Kamiya T, Takasugi M, et al. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci Immunol. 2022;7(72):eabl7209.","journal-title":"Sci Immunol"},{"issue":"10","key":"2020_CR75","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41568-023-00602-5","volume":"23","author":"A Jassim","year":"2023","unstructured":"Jassim A, Rahrmann EP, Simons BD, Gilbertson RJ. Cancers make their own luck: theories of cancer origins. Nat Rev Cancer. 2023;23(10):710\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2020_CR76","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-023-00660-9","volume":"24","author":"S Yuan","year":"2024","unstructured":"Yuan S, Almagro J, Fuchs E. Beyond genetics: driving cancer with the tumour microenvironment behind the wheel. Nat Rev Cancer. 2024;24(4):274\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"7913","key":"2020_CR77","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-022-04774-2","volume":"606","author":"ME Fane","year":"2022","unstructured":"Fane ME, Chhabra Y, Alicea GM, Maranto DA, Douglass SM, Webster MR, et al. Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature. 2022;606(7913):396\u2013405.","journal-title":"Nature"},{"issue":"4","key":"2020_CR78","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43018-023-00525-y","volume":"4","author":"FK Turrell","year":"2023","unstructured":"Turrell FK, Orha R, Guppy NJ, Gillespie A, Guelbert M, Starling C, et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER(+) breast cancer metastatic relapse. Nat Cancer. 2023;4(4):468\u201384.","journal-title":"Nat Cancer"},{"key":"2020_CR79","doi-asserted-by":"crossref","unstructured":"Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH 3, et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 2016;532(7598):250\u20134.","DOI":"10.1038\/nature17392"},{"issue":"7988","key":"2020_CR80","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-023-06740-y","volume":"623","author":"N Bansaccal","year":"2023","unstructured":"Bansaccal N, Vieugue P, Sarate R, Song Y, Minguijon E, Miroshnikova YA, et al. The extracellular matrix dictates regional competence for tumour initiation. Nature. 2023;623(7988):828\u201335.","journal-title":"Nature"},{"issue":"7977","key":"2020_CR81","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41586-023-06463-0","volume":"621","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Tian X, Lu JY, Boit K, Ablaeva J, Zakusilo FT, et al. Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice. Nature. 2023;621(7977):196\u2013205.","journal-title":"Nature"},{"issue":"3","key":"2020_CR82","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s43587-024-00581-8","volume":"4","author":"GE Marino-Bravante","year":"2024","unstructured":"Marino-Bravante GE, Carey AE, Huser L, Dixit A, Wang V, Kaur A, et al. Age-dependent loss of HAPLN1 erodes vascular integrity via indirect upregulation of endothelial ICAM1 in melanoma. Nat Aging. 2024;4(3):350\u201363.","journal-title":"Nat Aging"},{"issue":"8","key":"2020_CR83","doi-asserted-by":"publisher","first-page":"108779","DOI":"10.1016\/j.celrep.2021.108779","volume":"34","author":"T Yasuda","year":"2021","unstructured":"Yasuda T, Koiwa M, Yonemura A, Miyake K, Kariya R, Kubota S, et al. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. Cell Rep. 2021;34(8):108779.","journal-title":"Cell Rep"},{"issue":"3","key":"2020_CR84","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ccell.2019.08.001","volume":"36","author":"T O\u2019Connor","year":"2019","unstructured":"O\u2019Connor T, Zhou X, Kosla J, Adili A, Garcia Beccaria M, Kotsiliti E, et al. Age-related gliosis promotes central nervous system lymphoma through CCL19-mediated tumor cell retention. Cancer Cell. 2019;36(3):250\u201367. e9.","journal-title":"Cancer Cell"},{"issue":"7824","key":"2020_CR85","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2630-0","volume":"585","author":"AP Gomes","year":"2020","unstructured":"Gomes AP, Ilter D, Low V, Endress JE, Fernandez-Garcia J, Rosenzweig A, et al. Age-induced accumulation of methylmalonic acid promotes tumour progression. Nature. 2020;585(7824):283\u20137.","journal-title":"Nature"},{"issue":"11","key":"2020_CR86","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s42255-023-00916-6","volume":"5","author":"M Kovatcheva","year":"2023","unstructured":"Kovatcheva M, Melendez E, Chondronasiou D, Pietrocola F, Bernad R, Caballe A, et al. Vitamin B(12) is a limiting factor for induced cellular plasticity and tissue repair. Nat Metab. 2023;5(11):1911\u201330.","journal-title":"Nat Metab"},{"issue":"3","key":"2020_CR87","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tem.2023.11.001","volume":"35","author":"J Tejero","year":"2024","unstructured":"Tejero J, Lazure F, Gomes AP. Methylmalonic acid in aging and disease. Trends Endocrinol Metab. 2024;35(3):188\u2013200.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"2020_CR88","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3322\/caac.21818","volume":"74","author":"G Kroemer","year":"2024","unstructured":"Kroemer G, Chan TA, Eggermont AMM, Galluzzi L. Immunosurveillance in clinical cancer management. CA Cancer J Clin. 2024;74(2):187\u2013202.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2020_CR89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri1936","volume":"6","author":"L Zitvogel","year":"2006","unstructured":"Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715\u201327.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2020_CR90","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/acel.12455","volume":"15","author":"R Vicente","year":"2016","unstructured":"Vicente R, Mausset-Bonnefont AL, Jorgensen C, Louis-Plence P, Brondello JM. Cellular senescence impact on immune cell fate and function. Aging Cell. 2016;15(3):400\u20136.","journal-title":"Aging Cell"},{"key":"2020_CR91","doi-asserted-by":"publisher","first-page":"1338680","DOI":"10.3389\/fimmu.2024.1338680","volume":"15","author":"M Huang","year":"2024","unstructured":"Huang M, Wang Y, Fang L, Liu C, Feng F, Liu L, et al. T cell senescence: a new perspective on immunotherapy in lung cancer. Front Immunol. 2024;15:1338680.","journal-title":"Front Immunol"},{"issue":"7","key":"2020_CR92","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.ccell.2023.05.004","volume":"41","author":"S Haston","year":"2023","unstructured":"Haston S, Gonzalez-Gualda E, Morsli S, Ge J, Reen V, Calderwood A, et al. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell. 2023;41(7):1242\u201360. e6.","journal-title":"Cancer Cell"},{"issue":"7","key":"2020_CR93","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","volume":"41","author":"LI Prieto","year":"2023","unstructured":"Prieto LI, Sturmlechner I, Graves SI, Zhang C, Goplen NP, Yi ES, et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell. 2023;41(7):1261\u201375. e6.","journal-title":"Cancer Cell"},{"issue":"7814","key":"2020_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020;583(7814):127\u201332.","journal-title":"Nature"},{"issue":"7971","key":"2020_CR95","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","volume":"619","author":"DJ Baker","year":"2023","unstructured":"Baker DJ, Arany Z, Baur JA, Epstein JA, June CH. CAR T therapy beyond cancer: the evolution of a living drug. Nature. 2023;619(7971):707\u201315.","journal-title":"Nature"},{"issue":"7","key":"2020_CR96","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cell.2021.03.033","volume":"184","author":"C Lopez-Otin","year":"2021","unstructured":"Lopez-Otin C, Kroemer G. Hallmarks of health. Cell. 2021;184(7):1929\u201339.","journal-title":"Cell"},{"issue":"9","key":"2020_CR97","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1200\/JCO.23.01005","volume":"42","author":"SB Dixon","year":"2024","unstructured":"Dixon SB, Wang F, Lu L, Wilson CL, Green DM, Merchant TE, et al. Prediabetes and associated risk of cardiovascular events and chronic kidney disease among adult survivors of childhood cancer in the St Jude lifetime cohort. J Clin Oncol. 2024;42(9):1031\u201343.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020_CR98","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41571-023-00802-w","volume":"20","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt MJ, Krull KR, Bhakta N, Liu Q, Yasui Y, Robison LL, et al. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century. Nat Rev Clin Oncol. 2023;20(10):678\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2020_CR99","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S1470-2045(23)00154-7","volume":"24","author":"BV Dieffenbach","year":"2023","unstructured":"Dieffenbach BV, Murphy AJ, Liu Q, Ramsey DC, Geiger EJ, Diller LR, et al. Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS) cohort. Lancet Oncol. 2023;24(6):691\u2013700.","journal-title":"Lancet Oncol"},{"issue":"12","key":"2020_CR100","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S1470-2045(22)00637-4","volume":"23","author":"L Botta","year":"2022","unstructured":"Botta L, Gatta G, Capocaccia R, Stiller C, Canete A, Dal Maso L, et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncol. 2022;23(12):1525\u201336.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2020_CR101","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41467-023-37231-3","volume":"14","author":"WH Chang","year":"2023","unstructured":"Chang WH, Neal RD, Forster MD, Lai AG. Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers. Nat Commun. 2023;14(1):1484.","journal-title":"Nat Commun"},{"key":"2020_CR102","doi-asserted-by":"crossref","unstructured":"de Blank PMK, Lange KR, Xing M, Mirzaei Salehabadi S, Srivastava D, Brinkman TM et al. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study. Nat Cancer. 2024.","DOI":"10.1038\/s43018-024-00733-0"},{"issue":"29","key":"2020_CR103","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1200\/JCO.20.00493","volume":"38","author":"SB Dixon","year":"2020","unstructured":"Dixon SB, Chen Y, Yasui Y, Pui CH, Hunger SP, Silverman LB, et al. Reduced morbidity and mortality in survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol. 2020;38(29):3418\u201329.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020_CR104","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1158\/1078-0432.CCR-19-2503","volume":"26","author":"N Song","year":"2020","unstructured":"Song N, Li Z, Qin N, Howell CR, Wilson CL, Easton J, et al. Shortened leukocyte telomere length associates with an increased prevalence of chronic health conditions among survivors of childhood cancer: a report from the St. Jude lifetime cohort. Clin Cancer Res. 2020;26(10):2362\u201371.","journal-title":"Clin Cancer Res"},{"key":"2020_CR105","doi-asserted-by":"crossref","unstructured":"Guida JL, Hyun G, Belsky DW, Armstrong GT, Ehrhardt MJ, Hudson MM et al. Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude lifetime cohort. Nat Cancer. 2024.","DOI":"10.1038\/s43018-024-00745-w"},{"issue":"4","key":"2020_CR106","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1078-0432.CCR-20-3609","volume":"27","author":"S Bhatia","year":"2021","unstructured":"Bhatia S, Palomares MR, Hageman L, Chen Y, Landier W, Smith K, et al. A randomized phase IIb study of low-dose tamoxifen in chest-irradiated cancer survivors at risk for breast cancer. Clin Cancer Res. 2021;27(4):967\u201374.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2020_CR107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"Demaria M, O\u2019Leary MN, Chang J, Shao L, Liu S, Alimirah F, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017;7(2):165\u201376.","journal-title":"Cancer Discov"},{"key":"2020_CR108","doi-asserted-by":"publisher","first-page":"106356","DOI":"10.1016\/j.phrs.2022.106356","volume":"183","author":"A Lerida-Viso","year":"2022","unstructured":"Lerida-Viso A, Estepa-Fernandez A, Morella-Aucejo A, Lozano-Torres B, Alfonso M, Blandez JF, et al. Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice. Pharmacol Res. 2022;183:106356.","journal-title":"Pharmacol Res"},{"issue":"3","key":"2020_CR109","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-024-02837-7","volume":"30","author":"TM Gibson","year":"2024","unstructured":"Gibson TM, Karyadi DM, Hartley SW, Arnold MA, Berrington de Gonzalez A, Conces MR, et al. Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors. Nat Med. 2024;30(3):690\u20138.","journal-title":"Nat Med"},{"issue":"9","key":"2020_CR110","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/s41591-023-02514-1","volume":"29","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ronckers CM, van Leeuwen FE, Moskowitz CS, Leisenring W, Armstrong GT, et al. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nat Med. 2023;29(9):2268\u201377.","journal-title":"Nat Med"},{"issue":"23","key":"2020_CR111","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1200\/JCO.19.03166","volume":"38","author":"JA Beyea","year":"2020","unstructured":"Beyea JA, Lau C, Cooke B, Hall S, Nathan PC, Gupta S. Long-term incidence and predictors of significant hearing loss requiring hearing assistive devices among childhood cancer survivors: a population-based study. J Clin Oncol. 2020;38(23):2639\u201346.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020_CR112","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.21.02944","volume":"41","author":"EC de Baat","year":"2023","unstructured":"de Baat EC, Feijen EAM, Reulen RC, Allodji RS, Bagnasco F, Bardi E, et al. Risk factors for heart failure among Pan-european Childhood Cancer survivors: a PanCareSurFup and ProCardio cohort and nested case-control study. J Clin Oncol. 2023;41(1):96\u2013106.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020_CR113","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1200\/JCO.21.02613","volume":"41","author":"S de Vries","year":"2023","unstructured":"de Vries S, Haaksma ML, J\u00f3\u017awiak K, Schaapveld M, Hodgson DC, Lugtenburg PJ, et al. Development and validation of risk prediction models for coronary heart disease and heart failure after treatment for Hodgkin Lymphoma. J Clin Oncol. 2023;41(1):86\u201395.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2020_CR114","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41591-022-01902-3","volume":"28","author":"Y Sapkota","year":"2022","unstructured":"Sapkota Y, Qiu W, Dixon SB, Wilson CL, Wang Z, Zhang J, et al. Genetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer. Nat Med. 2022;28(8):1590\u20138.","journal-title":"Nat Med"},{"key":"2020_CR115","doi-asserted-by":"crossref","unstructured":"Wang M, Lan T, Williams AM, Ehrhardt MJ, Lanctot JQ, Jiang S et al. Plant foods intake and risk of premature aging in adult survivors of childhood cancer in the St Jude lifetime cohort (SJLIFE). J Clin Oncol. 2024:JCO2301260.","DOI":"10.1200\/JCO.23.01260"},{"issue":"10","key":"2020_CR116","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaoncol.2018.2254","volume":"4","author":"JM Scott","year":"2018","unstructured":"Scott JM, Li N, Liu Q, Yasui Y, Leisenring W, Nathan PC, et al. Association of exercise with mortality in adult survivors of childhood cancer. JAMA Oncol. 2018;4(10):1352\u20138.","journal-title":"JAMA Oncol"},{"key":"2020_CR117","doi-asserted-by":"crossref","unstructured":"Morales JS, Valenzuela PL, Vel\u00e1zquez-D\u00edaz D, Castillo-Garc\u00eda A, Jim\u00e9nez-Pav\u00f3n D, Lucia A et al. Exercise and childhood cancer-A historical review. Cancers (Basel). 2021;14(1).","DOI":"10.3390\/cancers14010082"},{"issue":"18","key":"2020_CR118","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1200\/JCO.19.02677","volume":"38","author":"E Barlow-Krelina","year":"2020","unstructured":"Barlow-Krelina E, Chen Y, Yasui Y, Till C, Gibson TM, Ness KK, et al. Consistent physical activity and future neurocognitive problems in adult survivors of childhood cancers: a report from the childhood cancer survivor study. J Clin Oncol. 2020;38(18):2041\u201352.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020_CR119","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41571-021-00580-3","volume":"19","author":"JE Carroll","year":"2022","unstructured":"Carroll JE, Bower JE, Ganz PA. Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care. Nat Rev Clin Oncol. 2022;19(3):173\u201387.","journal-title":"Nat Rev Clin Oncol"},{"issue":"24","key":"2020_CR120","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","volume":"22","author":"W Landier","year":"2004","unstructured":"Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the children\u2019s oncology group long-term follow-up guidelines from the children\u2019s oncology group late effects committee and nursing discipline. J Clin Oncol. 2004;22(24):4979\u201390.","journal-title":"J Clin Oncol"},{"key":"2020_CR121","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejca.2021.06.004","volume":"154","author":"RJ van Kalsbeek","year":"2021","unstructured":"van Kalsbeek RJ, van der Pal HJH, Kremer LCM, Bardi E, Brown MC, Effeney R, et al. European PanCareFollowUp recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer. Eur J Cancer. 2021;154:316\u201328.","journal-title":"Eur J Cancer"},{"issue":"4","key":"2020_CR122","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/pbc.24445","volume":"60","author":"LC Kremer","year":"2013","unstructured":"Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the international late effects of childhood cancer guideline harmonization group. Pediatr Blood Cancer. 2013;60(4):543\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2020_CR123","doi-asserted-by":"publisher","first-page":"110100","DOI":"10.1016\/j.celrep.2021.110100","volume":"37","author":"Y Shah","year":"2021","unstructured":"Shah Y, Verma A, Marderstein AR, White J, Bhinder B, Garcia Medina JS, et al. Pan-cancer analysis reveals molecular patterns associated with age. Cell Rep. 2021;37(10):110100.","journal-title":"Cell Rep"},{"key":"2020_CR124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.breast.2021.12.006","volume":"61","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Kim S, Freedman RA, Partridge AH. The impact of young age at diagnosis (age\u2009<\u200940 years) on prognosis varies by breast cancer subtype: a U.S. SEER database analysis. Breast. 2022;61:77\u201383.","journal-title":"Breast"},{"issue":"2","key":"2020_CR125","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.clml.2020.08.018","volume":"21","author":"A Rose","year":"2021","unstructured":"Rose A, Grajales-Cruz A, Lim A, Todd A, Bello C, Shah B, et al. Classical Hodgkin Lymphoma: clinicopathologic features, prognostic factors, and outcomes from a 28-Year single institutional experience. Clin Lymphoma Myeloma Leuk. 2021;21(2):132\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"2020_CR126","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1001\/jamaoncol.2021.4960","volume":"7","author":"CA Nebhan","year":"2021","unstructured":"Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, et al. Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a Multicenter International Cohort Study. JAMA Oncol. 2021;7(12):1856\u201361.","journal-title":"JAMA Oncol"},{"issue":"19","key":"2020_CR127","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1200\/JCO.21.00138","volume":"39","author":"CJ Presley","year":"2021","unstructured":"Presley CJ, Gomes F, Burd CE, Kanesvaran R, Wong ML. Immunotherapy in older adults with cancer. J Clin Oncol. 2021;39(19):2115\u201327.","journal-title":"J Clin Oncol"},{"key":"2020_CR128","doi-asserted-by":"crossref","unstructured":"Shafqat S, Arana Chicas E, Shafqat A, Hashmi SK. The Achilles\u2019 heel of cancer survivors: fundamentals of accelerated cellular senescence. J Clin Invest. 2022;132(13).","DOI":"10.1172\/JCI158452"},{"issue":"16","key":"2020_CR129","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1200\/JCO.21.02656","volume":"40","author":"A Amini","year":"2022","unstructured":"Amini A, Morris L, Ludmir EB, Movsas B, Jagsi R, VanderWalde NA. Radiation therapy in older adults with cancer: a critical modality in geriatric oncology. J Clin Oncol. 2022;40(16):1806\u201311.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2020_CR130","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S1470-2045(20)30538-6","volume":"21","author":"JA Crozier","year":"2020","unstructured":"Crozier JA, Pezzi TA, Hodge C, Janeva S, Lesnikoski BA, Samiian L, et al. Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis. Lancet Oncol. 2020;21(12):1611\u20139.","journal-title":"Lancet Oncol"},{"issue":"60","key":"2020_CR131","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jncimonographs\/lgac023","volume":"2022","author":"J Le-Rademacher","year":"2022","unstructured":"Le-Rademacher J, Mohile S, Unger J, Hudson MF, Foster J, Lichtman S, et al. Trial design considerations to increase older adult accrual to national cancer institute clinical trials. J Natl Cancer Inst Monogr. 2022;2022(60):135\u201341.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"2020_CR132","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/caac.21638","volume":"71","author":"MS Sedrak","year":"2021","unstructured":"Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78\u201392.","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"2020_CR133","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1200\/JCO.18.02067","volume":"37","author":"P Fang","year":"2019","unstructured":"Fang P, Jagsi R, He W, Lei X, Campbell EG, Giordano SH, et al. Rising and falling trends in the use of chemotherapy and targeted therapy near the end of life in older patients with cancer. J Clin Oncol. 2019;37(20):1721\u201331.","journal-title":"J Clin Oncol"},{"issue":"22","key":"2020_CR134","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1200\/JCO.19.02809","volume":"38","author":"C DuMontier","year":"2020","unstructured":"DuMontier C, Loh KP, Bain PA, Silliman RA, Hshieh T, Abel GA, et al. Defining undertreatment and overtreatment in older adults with cancer: a scoping literature review. J Clin Oncol. 2020;38(22):2558\u201369.","journal-title":"J Clin Oncol"},{"issue":"19","key":"2020_CR135","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1200\/JCO.21.00165","volume":"39","author":"C DuMontier","year":"2021","unstructured":"DuMontier C, Loh KP, Soto-Perez-de-Celis E, Dale W. Decision making in older adults with cancer. J Clin Oncol. 2021;39(19):2164\u201374.","journal-title":"J Clin Oncol"},{"issue":"26","key":"2020_CR136","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.23.00933","volume":"41","author":"W Dale","year":"2023","unstructured":"Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293\u2013312.","journal-title":"J Clin Oncol"},{"key":"2020_CR137","unstructured":"F.D.A. Guidance for Industry - Inclusion of Older Adults in Cancer Clinical Trials. FDA-2019-D-55722022. p. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/inclusion-older-adults-cancer-clinical-trials"},{"issue":"12","key":"2020_CR138","doi-asserted-by":"publisher","first-page":"e1025","DOI":"10.1200\/JOP.2016.013136","volume":"12","author":"A Hurria","year":"2016","unstructured":"Hurria A, Akiba C, Kim J, Mitani D, Loscalzo M, Katheria V, et al. Reliability, validity, and feasibility of a computer-based geriatric assessment for older adults with cancer. J Oncol Pract. 2016;12(12):e1025\u201334.","journal-title":"J Oncol Pract"},{"issue":"1","key":"2020_CR139","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/S1470-2045(20)30473-3","volume":"22","author":"M Extermann","year":"2021","unstructured":"Extermann M, Brain E, Canin B, Cherian MN, Cheung KL, de Glas N, et al. Priorities for the global advancement of care for older adults with cancer: an update of the international society of geriatric oncology priorities initiative. Lancet Oncol. 2021;22(1):e29\u201336.","journal-title":"Lancet Oncol"},{"issue":"34","key":"2020_CR140","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1200\/JCO.23.01337","volume":"41","author":"D Ioffe","year":"2023","unstructured":"Ioffe D, Dotan E. Evidence-based care of older adults with metastatic colorectal cancer: insights from landmark clinical trials. J Clin Oncol. 2023;41(34):5228\u201336.","journal-title":"J Clin Oncol"},{"issue":"10314","key":"2020_CR141","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894\u2013904.","journal-title":"Lancet"},{"issue":"2","key":"2020_CR142","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.22.00406","volume":"41","author":"JE Carroll","year":"2023","unstructured":"Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, et al. Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast Cancer survivors: the thinking and living with cancer study. J Clin Oncol. 2023;41(2):295\u2013306.","journal-title":"J Clin Oncol"},{"issue":"19","key":"2020_CR143","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1200\/JCO.21.00245","volume":"39","author":"MS Sedrak","year":"2021","unstructured":"Sedrak MS, Gilmore NJ, Carroll JE, Muss HB, Cohen HJ, Dale W. Measuring biologic resilience in older cancer survivors. J Clin Oncol. 2021;39(19):2079\u201389.","journal-title":"J Clin Oncol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-024-02020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:29:57Z","timestamp":1715988597000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":143,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1186\/s12943-024-02020-z","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review article, meaning that no ethical approval is needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"GK has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sutro, Tollys, and Vascage. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. GK is in the scientific advisory boards of Hevolution, Institut Servier, Longevity Vision Funds and Rejuveron Life Sciences. GK is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis and metabolic disorders. GK\u2019s wife, Laurence Zitvogel, has held research contracts with Glaxo Smyth Kline, Incyte, Lytix, Kaleido, Innovate Pharma, Daiichi Sankyo, Pilege, Merus, Transgene, 9\u00a0m, Tusk and Roche, was on the on the Board of Directors of Transgene, is a cofounder of everImmune, and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. GK\u2019s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. The funders had no role in the design of the study; in the writing of the manuscript, or in the decision to publish the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}